Abstract:Aim: The prognosis for gastric cancer (GC) remains grim, underscoring the importance of accurate staging and treatment. Given the potential benefits of using lymph node ratio (LNR) for improved prognostication and treatment planning, it is critical to incorporate examined lymph nodes (ELN) count in an integrated GC staging system. Methods: Patients data from the Surveillance, Epidemiology, and End Results (SEER) database between 2010 and 2015 was utilized as training set. The Mantel-Cox survival test was used to calculate chi-square values for 40 LNR segments with a 0.025 interval, defining a novel LNR-based N (rN) classification based on the cutoff points. A revised AJCC (rAJCC) staging system was established by replacing the 8th AJCC N staging with a rN classification. The relationship between the ELN count and prognosis or positive lymph node detection was conducted by using multivariable models. The series of the odds ratios and hazard ratios were fitted with a locally weighted scatterplot smoothing (LOWESS) smoother, and the structural break points were determined by Chow test to clarify an optimal minimum ELN count. The integrated GC staging system incorporated both rAJCC system and the ideal ELN count. Discriminatory ability and prognostic homogeneity of the rAJCC and integrated staging system was compared with AJCC staging system in the SEER validation set (2016-2017), the Cancer Genome Atlas Program (TCGA) database, and the Third Affiliated Hospital of Sun Yat-sen University database. Results: The current study found that LNR and ELN count are both significantly associated with the prognosis of GC patients (HR = 0.98, p < 0.001 and HR = 2.51, p < 0.001). Four peaks of the chi-square value were identified as LNR cut-off points at 0.025, 0.175, 0.45 and 0.6 to define a novel rN stage. In comparison to the 8th AJCC staging system, the rAJCC staging system demonstrated significant prognostic advantages and discriminatory ability in the training set (5-Y OS AUC: 71.7 vs. 73.0; AIC: 57,290.7 vs. 57,054.9). The superiority of the rAJCC staging system was confirmed in all validation sets. Using a LOWESS smoother and Chow test, a threshold ELN count of 30 was determined to maximum improvement in the prognosis of node-negative patients without downgrading due to potential metastasis, while also maximizing the detection efficiency of at least one involved lymph node. The integrated staging system, combining the refined rAJCC classification with an optimized ELN count threshold, has demonstrated superior discriminatory performance compared to the standalone rAJCC or the traditional AJCC system. Conclusion: The development of a novel GC staging system, which integrated the LNR-based N classification and the minimum ELN count, has exhibited superior prognostic accuracy, holding promise as a valuable asset in the clinical management of GC. However, it is crucial to recognize the limitations from the retrospective database, which should be addressed in subsequent analyses.

Modified Gastric Cancer AJCC Staging with a Classification Based on the Ratio of Regional Lymph Node Involvement: A Population-Based Cohort Study

Prognostic value of a modified pathological staging system for gastric cancer based on the number of retrieved lymph nodes and metastatic lymph node ratio

Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis

Comparison of a Tumor-Ratio–Metastasis Staging System and the 8th AJCC TNM Staging System for Gastric Cancer

Proposed Modification of the 8th Edition of the AJCC Staging System for Gastric Cancer

Proposal for a New TNM Stage Based on the 7th and 8th American Joint Committee on Cancer Ptnm Staging Classification for Gastric Cancer

Standardizing the Classification of Gastric Cancer Patients with Limited and Adequate Number of Retrieved Lymph Nodes: an Externally Validated Approach Using Real-World Data.

Proposal of a new lymph node staging system for gastric cancer: study from two institutions in China

Lymph node ratio-based the ypTNrM staging system for gastric cancer after neoadjuvant therapy: a large population-based study

A comparative study of the application of AJCC 6th and 7th edition gastric cancer staging systems in remnant gastric cancer and the establishment of a prognosis prediction model

Comparison of metastatic lymph node ratio staging system with the 7th AJCC system for colorectal cancer

A New Pn Staging System Based on Both the Number and Anatomic Location of Metastatic Lymph Nodes in Gastric Cancer

Development and validation of a new staging system for node-negative gastric cancer based on recursive partitioning analysis: An international multi-institutional study.

Tumor-ratio-metastasis Staging System As an Alternative to the 7th Edition UICC TNM System in Gastric Cancer after D2 Resection--results of a Single-Institution Study of 1343 Chinese Patients.

The Prognosis Role of AJCC/UICC 8th Edition Staging System in Gastric Cancer, a Retrospective Analysis.

Is the 8th Edition of the AJCC TNM Staging System Sufficiently Reasonable for All Patients with Noncardia Gastric Cancer? A 12,549-Patient International Database Study

Evaluation of the Eighth Edition of the American Joint Committee on Cancer TNM Staging System for Gastric Cancer: an Analysis of 7371 Patients in the SEER Database

Superiority of Lymph Node Ratio-Based Staging System for Prognostic Prediction in 2575 Patients with Gastric Cancer: Validation Analysis in A Large Single Center

Prognostic Performance Of Lymph Node Staging Systems In Patients With Resectable Gastric Cancer: Comparison Of Population-Based Nomograms.

Assessment of Lymph Node Ratio to Replace the Pn Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma.

Validation of the American Joint Commission on Cancer (8th Edition) Changes for Patients with Stage III Gastric Cancer: Survival Analysis of a Large Series from a Specialized Eastern Center.